Candel Therapeutics (CADL) Profit After Tax (2020 - 2025)
Candel Therapeutics (CADL) posted Profit After Tax of -$29.5 million for Q4 2025, down 161.78% sequentially from -$11.3 million in Q3 2025, and down 109.62% YoY from $306.6 million in Q4 2024.
Candel Therapeutics (CADL) Profit After Tax (2020 - 2025) Analysis & Trends
Candel Therapeutics has reported Profit After Tax for 6 years, with the latest figure at -$29.5 million in Q4 2025.
- Quarterly Profit After Tax fell 109.62% year-over-year to -$29.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$38.2 million (up 30.77% YoY) and the FY2025 annual result came in at -$38.2 million, up 30.77% from the prior year.
- Profit After Tax slipped to -$29.5 million in Q4 2025 per CADL's latest filing, from -$11.3 million in the prior quarter.
- Over five years, Profit After Tax peaked at $7.4 million in Q1 2025 and troughed at -$29.5 million in Q4 2025.
- A 5-year average of -$9.3 million and a median of -$8.7 million in 2022 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2023 and 2025: Profit After Tax tumbled 906.86% in 2023, then surged 189.99% in 2025.
- Over 5 years, Profit After Tax stood at $1.6 million in 2021, then tumbled by 419.17% to -$5.1 million in 2022, then tumbled by 117.9% to -$11.1 million in 2023, then dropped by 26.78% to -$14.1 million in 2024, then sank by 109.62% to -$29.5 million in 2025.
- According to Business Quant data, Profit After Tax over the past three periods registered -$29.5 million, -$11.3 million, and -$4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Candel Therapeutics | 643.41 Mn | 643.41 Mn | - | -29.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29.50 Mn |
| Sep 30, 2025 | -11.27 Mn |
| Jun 30, 2025 | -4.80 Mn |
| Mar 31, 2025 | 7.38 Mn |
| Dec 31, 2024 | -14.07 Mn |
| Sep 30, 2024 | -10.65 Mn |
| Jun 30, 2024 | -22.24 Mn |
| Mar 31, 2024 | -8.20 Mn |
| Dec 31, 2023 | -11.10 Mn |
| Sep 30, 2023 | -8.44 Mn |
| Jun 30, 2023 | -9.61 Mn |
| Mar 31, 2023 | -8.80 Mn |
| Dec 31, 2022 | -5.09 Mn |
| Sep 30, 2022 | -8.69 Mn |
| Jun 30, 2022 | -4.15 Mn |
| Mar 31, 2022 | -874,000.00 |
| Dec 31, 2021 | 1.60 Mn |
| Sep 30, 2021 | -16.16 Mn |
| Jun 30, 2021 | -17.08 Mn |
| Mar 31, 2021 | -4.48 Mn |